SCHEMBL12912433

SCHEMBL12912433

c1ccc(-c2nc3ccccc3n2-c2cccc(-c3ccc4ccc5cccc6ccc3c4c56)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.49
▸ ESR2 Q92731 1/20 0.49
▸ GAA P10253 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ RECQL P46063 1/20 0.41
▸ GRIA1 P42261 1/20 0.40
▸ CACNG8 Q8WXS5 1/20 0.40
▸ CACNG2 Q9Y698 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ HPGD P15428 1/20 0.39
▸ PDE6D O43924 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9976947 0.92 ESR1 (0.49) ESR1ESR2GAAMEN1KMT2A
SCHEMBL12912480 0.92 ESR1 (0.48) ESR1ESR2GAAMEN1KMT2A
SCHEMBL16604617 0.91 ESR1 (0.48) ESR1ESR2GAAMEN1KMT2A
SCHEMBL10041759 0.90 ESR1 (0.51) ESR1ESR2GAAMEN1KMT2A
SCHEMBL9976944 0.89 ESR1 (0.56) ESR1ESR2MEN1KMT2AHDAC1
SCHEMBL14506134 0.88 ESR1 (0.44) ESR1ESR2GAAMEN1KMT2A
SCHEMBL9976946 0.88 ESR1 (0.55) ESR1ESR2MEN1KMT2AHDAC1
SCHEMBL9976949 0.88 ESR1 (0.55) ESR1ESR2MEN1KMT2AHDAC1
SCHEMBL9976943 0.88 ESR1 (0.43) ESR1ESR2GAAMEN1KMT2A
SCHEMBL12611786 0.87 RECQL (0.44) ESR1ESR2GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NUDC, TYR, NUDT1 ESR1 563/4885ESR2 1585/4885GAA 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback